The potential Ebola vaccine could be in the hands of people by the end of this week, according to the Centers for Disease Control and Prevention (CDC).
On Tuesday, the CDC announced that the vaccine had been approved for use by a “large number of people” and that it would begin rolling out to the general population next week.
“The number of confirmed cases has decreased substantially,” Dr. David Nabarro, deputy director of the CDC’s National Center for Immunization and Respiratory Diseases, said in a press release.
“These are people who have tested positive for Ebola and have not been hospitalized.
We’re now seeing a significant reduction in the number of cases.”
Nabarro said there was a “significant number of vaccine candidates that are now in the testing phase.”
Nebarro told reporters that the Ebola vaccine is being tested by the CDC in the same way the vaccine was tested in Europe, where the virus was found to be circulating.
“We’re working very closely with the CDC and are ready to go,” he said.
“I know we are going to have a great response, but we are very excited about the vaccine.”
The US has seen a steady decline in the recent number of reported cases since the first person was diagnosed with the virus in the country.
On Thursday, the World Health Organization (WHO) warned that more than 9,500 people had been diagnosed with Ebola in Guinea, Liberia and Sierra Leone since January.